Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Phoenix › NPI 1376585166
Physician

Patterson Schlotterer Medical Group

Patterson Schlotterer Medical Group was paid $6.41M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.

33Billing provider infoPATTERSON SCHLOTTERER MEDICAL GROUP
PHOENIX, AZ 85003
33aNPI1376585166assigned 06/13/2006
33bProvider typePediatrics Physician
28Total paid$6.41M
24GClaims166,284
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Arizona

Rank by total paid#14 of 235
Median peer was paid$164K
This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201822,858$860K
201925,151$823K
202025,088$777K
202127,441$1.04M
202226,157$1.11M
202323,206$1.00M
2024incomplete16,383$793K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 50% 42,477 36,889 $3.19M
90460 Immunization administration through 18 years of age via any route, first or only component 6.9% 14,621 14,306 $441K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 6.6% 4,836 4,783 $422K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.3% 5,084 5,040 $404K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.7% 6,702 6,441 $367K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4.4% 3,595 3,559 $284K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.5% 2,960 2,921 $221K
87428 2.7% 2,790 2,731 $175K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.2% 5,665 5,509 $80K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,734 1,490 $64K
90461 <1% 2,538 2,341 $59K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 964 917 $56K
70 more codes
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 1,660 $53K
92551 <1% 7,398 $50K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 747 $42K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials <1% 219 $42K
99215 Doctor's office visit, returning patient (complex) <1% 357 $42K
99203 Doctor's office visit, new patient (routine) <1% 644 $41K
81002 <1% 12,316 $35K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,018 $30K
0071A <1% 363 $30K
0001A <1% 522 $27K
0002A <1% 479 $26K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 296 $23K
99177 <1% 1,639 $22K
0004A <1% 252 $20K
0072A <1% 207 $17K
99402 <1% 385 $16K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 156 $14K
99204 Doctor's office visit, new patient (more involved) <1% 127 $13K
99173 <1% 7,323 $13K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 558 $12K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 303 $11K
96127 <1% 2,025 $9K
0124A <1% 119 $9K
94010 <1% 293 $9K
99383 <1% 78 $7K
99000 <1% 724 $5K
99384 <1% 48 $5K
0011A <1% 103 $4K
90620 <1% 919 $3K
0012A <1% 69 $3K
94760 <1% 2,443 $2K
86580 <1% 329 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 138 $2K
87807 <1% 118 $2K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,233 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 31 $1K
95117 <1% 167 $1K
90686 <1% 5,225 $1K
99381 <1% 15 $1K
0074A <1% 12 $996.00
96160 <1% 145 $497.56
94761 <1% 172 $334.52
90651 <1% 1,284 $300.00
90619 <1% 126 $274.59
90715 <1% 118 $192.84
A7015 Aerosol mask, used with dme nebulizer <1% 155 $148.73
99188 <1% 12 $129.91
87070 <1% 440 $114.64
94150 <1% 364 $83.49
90672 <1% 354 $28.09
90677 <1% 91 $13.89
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 157 $6.71
J7510 Prednisolone oral, per 5 mg <1% 12 $0.61
90670 <1% 1,693 $0.02
90674 0% 399 $0.00
3008F 0% 7,336 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 2,555 $0.00
90698 0% 746 $0.00
90744 0% 269 $0.00
90696 0% 42 $0.00
1220F 0% 349 $0.00
90680 0% 13 $0.00
91301 0% 29 $0.00
90681 0% 175 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 1,124 $0.00
90710 0% 371 $0.00
99072 0% 495 $0.00
90734 0% 676 $0.00
90633 0% 520 $0.00
90685 0% 38 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHLOTTERER, MARY (PRESIDENT)